Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• AranVVictorinoAPThulerLCFerreiraCGColorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortalityClin Colorectal Cancer201615319520326964802
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
   PubMed Web of Science ®Google Scholar
• De GreefKRolfoCRussoAMultidisciplinary management of patients with liver metastasis from colorectal cancerWorld J Gastroenterol201622327215722527621569
   PubMedGoogle Scholar
• TroianiTNapolitanoSDella CorteCMTherapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidenceESMO Open201615e00008827843640
   PubMed Web of Science ®Google Scholar
• ParikhRBPrasadVBlood-based screening for colon cancer: a disruptive innovation or simply a disruption?JAMA2016315232519252027305625
   PubMed Web of Science ®Google Scholar
• SepulvedaARHamiltonSRAllegraCJMolecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical OncologyJ Clin Oncol201735131453148628165299
   PubMed Web of Science ®Google Scholar
• TsilimigrasMCFodorAJobinCCarcinogenesis and therapeutics: the microbiota perspectiveNat Microbiol201721700828225000
   PubMed Web of Science ®Google Scholar
• GagnaireANadelBRaoultDNeefjesJGorvelJPCollateral damage: insights into bacterial mechanisms that predispose host cells to cancerNat Rev Microbiol201715210912828045107
   PubMed Web of Science ®Google Scholar
• DartATumour microenvironment: that gut feelingNat Rev Cancer20161612756757
   PubMedGoogle Scholar
• O’ConnorAO’MorainCAFordACPopulation screening and treatment of Helicobacter pylori infectionNat Rev Gastroenterol Hepatol201714423024028053340
   PubMed Web of Science ®Google Scholar
• WangJJiaHMetagenome-wide association studies: fine-mining the microbiomeNat Rev Microbiol201614850852227396567
   PubMedGoogle Scholar
• TsoiHChuESZhangXPeptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in miceGastroenterology201715261419143328126350
   PubMed Web of Science ®Google Scholar
• WangXYangYHuyckeMMCommensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effectGut201564345946824906974
   PubMedGoogle Scholar
• ZhuQJinZWuWAnalysis of the intestinal lumen microbiota in an animal model of colorectal cancerPLoS One201496e9084924603888
   PubMedGoogle Scholar
• GaoZGuoBGaoRZhuQQinHMicrobiota disbiosis is associated with colorectal cancerFront Microbiol201562025699023
   PubMed Web of Science ®Google Scholar
• YangYWengWPengJFusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21Gastroenterology2017152485186627876571
   PubMed Web of Science ®Google Scholar
• PradellaDNaroCSetteCGhignaCEMT and stemness: flexible processes tuned by alternative splicing in development and cancer progressionMol Cancer2017161828137272
   PubMed Web of Science ®Google Scholar
• ChenTYouYJiangHWangZZEpithelial–mesenchymal transition (EMT): a biological process in the development, stem cell differentiation and tumorigenesisJ Cell Physiol2017232123261327228079253
   PubMed Web of Science ®Google Scholar
• YanXLiuLLiHDual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancerAm J Cancer Res20166102323233327822421
   PubMedGoogle Scholar
• DalerbaPSahooDPaikSCDX2 as a prognostic biomarker in stage II and stage III colon cancerN Engl J Med2016374321122226789870
   PubMed Web of Science ®Google Scholar
• HanYWFusobacterium nucleatum: a commensal-turned pathogenCurr Opin Microbiol20152314114725576662
   PubMed Web of Science ®Google Scholar
• TaharaTShibataTKawamuraTFusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in JapanDig Dis Sci201560120521025102986
   PubMed Web of Science ®Google Scholar
• AtanasovaKRYilmazOPrelude to oral microbes and chronic diseases: past, present and futureMicrobes Infect201517747348325813714
   PubMed Web of Science ®Google Scholar
• StockhamSStamfordJERobertsCTAbnormal pregnancy outcomes in mice using an induced periodontitis model and the haematogenous migration of Fusobacterium nucleatum sub-species to the murine placentaPLoS One2015103e012005025806806
   PubMed Web of Science ®Google Scholar
• YamamuraKBabaYNakagawaSHuman microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosisClin Cancer Res201622225574558127769987
   PubMed Web of Science ®Google Scholar
• MitsuhashiKNoshoKSukawaYAssociation of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosisOncotarget2015697209722025797243
   PubMedGoogle Scholar
• CastellarinMWarrenRLFreemanJDFusobacterium nucleatum infection is prevalent in human colorectal carcinomaGenome Res201222229930622009989
   PubMed Web of Science ®Google Scholar
• SaitoTNishikawaHWadaHTwo FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancersNat Med201622667968427111280
   PubMed Web of Science ®Google Scholar
• GurCIbrahimYIsaacsonBBinding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attackImmunity201542234435525680274
   PubMed Web of Science ®Google Scholar
• MimaKSukawaYNishiharaRFusobacterium nucleatum and T cells in colorectal carcinomaJAMA Oncol20151565366126181352
   PubMed Web of Science ®Google Scholar
• ItoMKannoSNoshoKAssociation of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathwayInt J Cancer201513761258126825703934
   PubMed Web of Science ®Google Scholar
• LiSKonstantinovSRSmitsRPeppelenboschMPBacterial biofilms in colorectal cancer initiation and progressionTrends Mol Med2017231183027986421
   PubMed Web of Science ®Google Scholar
• LiYYGeQXCaoJAssociation of Fusobacterium nucleatum infection with colorectal cancer in Chinese patientsWorld J Gastroenterol201622113227323327004000
   PubMedGoogle Scholar
• MimaKNishiharaRQianZRFusobacterium nucleatum in colorectal carcinoma tissue and patient prognosisGut201665121973198026311717
   PubMed Web of Science ®Google Scholar
• FlanaganLSchmidJEbertMFusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcomeEur J Clin Microbiol Infect Dis20143381381139024599709
   PubMed Web of Science ®Google Scholar
• HuangBChenCNiMMoSCaiGCaiSLog odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: a retrospective analysis of 17,632 patients in the SEER databaseInt J Surg201632243027321382
   PubMedGoogle Scholar
• LiQLiangLJiaHNegative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancerOncotarget2016744722907229927474167
   PubMedGoogle Scholar
• ChuQDZhouMMedeirosKPeddiPPositive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancerSurgery201616051333134327425043
   PubMedGoogle Scholar
• ChuQDZhouMMedeirosKLPeddiPKavanaughMWuXCPoor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapyBMC Cancer20161646027412163
   PubMedGoogle Scholar
• WongSHKwongTNChowTCQuantitation of faecal Fuso-bacterium improves faecal immunochemical test in detecting advanced colorectal neoplasiaGut20176681441144827797940
   PubMed Web of Science ®Google Scholar
• LiangQChiuJChenYFecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancerClin Cancer Res20172382061207027697996
   PubMed Web of Science ®Google Scholar
• AlexanderJLWilsonIDTeareJMarchesiJRNicholsonJKKinrossJMGut microbiota modulation of chemotherapy efficacy and toxicityNat Rev Gastroenterol Hepatol201714635636528270698
   PubMed Web of Science ®Google Scholar
• YuTGuoFYuYFusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagyCell2017170354856328753429
   PubMed Web of Science ®Google Scholar
• RajagopalaSVYoosephSHarkinsDMGastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosisBMC Genomics201617163527527070
   PubMedGoogle Scholar
• IshiwataTCancer stem cells and epithelial–mesenchymal transition: novel therapeutic targets for cancerPathol Int2016661160160827510923
   PubMedGoogle Scholar
• YanXYanLLiuSShanZTianYJinZN-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancerMol Med Rep20151222999300625936636
   PubMed Web of Science ®Google Scholar
• MengHMZhengPWangXYOver-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancerCancer Biol Ther20109429530220026903
   PubMed Web of Science ®Google Scholar
• ZhouHHuYUWangWExpression of Oct-4 is significantly associated with the development and prognosis of colorectal cancerOncol Lett201510269169626622555
   PubMed Web of Science ®Google Scholar
• Serrano-GomezSJMaziveyiMAlahariSKRegulation of epithelial–mesenchymal transition through epigenetic and post-translational modificationsMol Cancer2016151826905733
   PubMed Web of Science ®Google Scholar
• RubinsteinMRWangXLiuWHaoYCaiGHanYWFusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesinCell Host Microbe201314219520623954158
   PubMed Web of Science ®Google Scholar
• ShiCYangYXiaYNovel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancerGut20166591470148125994220
   PubMedGoogle Scholar
• PanQMengLYeJTranscriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial–mesenchymal transition (EMT)Cancer Lett2017392263828163188
   PubMed Web of Science ®Google Scholar
• MigitaTUedaAOhishiTEpithelial–mesenchymal transition promotes SOX2 and NANOG expression in bladder cancerLab Invest Epub2017227
   PubMedGoogle Scholar
• KodachLLJacobsRJVoorneveldPWStatins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathwayGut201160111544155321551187
   PubMed Web of Science ®Google Scholar